Related Experiment Video

Updated: Apr 15, 2026

Induction of Mesenchymal-Epithelial Transitions in Sarcoma Cells
11:42

Induction of Mesenchymal-Epithelial Transitions in Sarcoma Cells

Published on: April 7, 2017

10.0K

Tumor suppressive microRNA-200a inhibits renal cell carcinoma development by directly targeting TGFB2

Ruijing Lu1,2, Ziliang Ji3, Xiaoqing Li1

  • 1Central Laboratory, Peking University Shenzhen Hospital, Shenzhen, 518036, China.

Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine
|March 28, 2015
PubMed

Insights

MicroRNA-200a (miR-200a) is downregulated in renal cell carcinoma (RCC). Restoring miR-200a inhibits RCC cell growth and spread by targeting transforming growth factor beta2 (TGFB2).

Area of Science:

  • Molecular Biology
  • Oncology
  • Gene Regulation

Background:

  • MicroRNAs are key regulators in cancer development, influencing oncogenes and tumor suppressor genes.
  • Dysregulation of microRNAs is implicated in tumor initiation and progression.
  • Renal cell carcinoma (RCC) is a significant malignancy with complex molecular underpinnings.

Purpose of the Study:

  • To investigate the role of miR-200a in renal cell carcinoma (RCC).
  • To identify and validate direct target genes of miR-200a in RCC.
  • To explore the therapeutic potential of miR-200a in RCC.

Main Methods:

  • Quantitative analysis of miR-200a expression in RCC patient samples.
  • In vitro experiments assessing the effects of miR-200a restoration on RCC cell proliferation, migration, and invasion.
  • Epithelial-to-mesenchymal transition PCR array to identify potential miR-200a targets.
  • Validation of target genes using quantitative real-time PCR, ELISA, and luciferase reporter assays.
  • siRNA-mediated knockdown of identified target genes to assess functional impact.

Main Results:

  • miR-200a expression was significantly downregulated in 45 RCC samples.
  • Restoration of miR-200a suppressed proliferation, migration, and invasion in RCC cell lines.
  • Transforming growth factor beta2 (TGFB2) was identified and validated as a direct target of miR-200a.
  • Knockdown of TGFB2 partially mimicked the tumor-suppressive effects of miR-200a overexpression.

Conclusions:

  • miR-200a acts as a tumor suppressor in RCC by directly targeting TGFB2.
  • The miR-200a/TGFB2 axis plays a critical role in RCC development.
  • miR-200a represents a potential novel diagnostic biomarker and therapeutic target for RCC.
Keywords:
Renal cell carcinomaTGFB2Tumor suppressormiR-200a

More Related Videos

Analysis of Combinatorial miRNA Treatments to Regulate Cell Cycle and Angiogenesis11:44

Analysis of Combinatorial miRNA Treatments to Regulate Cell Cycle and Angiogenesis

Published on: March 30, 2019

8.1K
MicroRNA In situ Hybridization for Formalin Fixed Kidney Tissues12:21

MicroRNA In situ Hybridization for Formalin Fixed Kidney Tissues

Published on: November 30, 2013

15.4K

Related Concept Videos

MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After...
24.8K
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
4.3K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
5.1K
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
10.4K
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

3.1K
The Retinoblastoma Gene01:20

The Retinoblastoma Gene

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
5.0K